PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 217 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $155,000 | -83.4% | 21,745 | -37.3% | 0.00% | -100.0% |
| Q3 2019 | $931,000 | -78.5% | 34,696 | -84.4% | 0.00% | -80.0% |
| Q4 2018 | $4,337,000 | +66.9% | 222,200 | +127.7% | 0.01% | +100.0% |
| Q3 2018 | $2,599,000 | +47.3% | 97,600 | +109.0% | 0.01% | +66.7% |
| Q2 2018 | $1,764,000 | +2.9% | 46,700 | -11.0% | 0.00% | 0.0% |
| Q1 2018 | $1,715,000 | -13.4% | 52,500 | +29.0% | 0.00% | -25.0% |
| Q4 2017 | $1,981,000 | +1012.9% | 40,700 | +1133.3% | 0.00% | – |
| Q3 2017 | $178,000 | – | 3,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |